NCT00002087View on ClinicalTrials.gov

Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Alvircept sudotox

Trial Locations (1)

943055107

Stanford Univ Med Ctr, Stanford

All Listed Sponsors

lead

Pharmacia and Upjohn

INDUSTRY